Volume 86, Issue 5, Pages (November 2014)

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 66, Issue 6, Pages (December 2004)
Volume 78, Issue 12, Pages (December 2010)
Increased expression of heparanase in overt diabetic nephropathy
Volume 80, Issue 1, Pages (July 2011)
Volume 83, Issue 5, Pages (May 2013)
Volume 81, Issue 11, Pages (June 2012)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 79, Issue 9, Pages (May 2011)
Volume 81, Issue 11, Pages (June 2012)
Volume 65, Issue 2, Pages (February 2004)
Volume 78, Issue 11, Pages (December 2010)
Volume 85, Issue 3, Pages (March 2014)
Volume 72, Issue 10, Pages (November 2007)
Heparan sulfate proteoglycans in glomerular inflammation
Volume 65, Issue 4, Pages (April 2004)
Volume 85, Issue 5, Pages (May 2014)
Volume 81, Issue 2, Pages (January 2012)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 78, Issue 12, Pages (December 2010)
Volume 79, Issue 4, Pages (February 2011)
Volume 82, Issue 8, Pages (October 2012)
Volume 72, Issue 6, Pages (September 2007)
Volume 82, Issue 1, Pages (July 2012)
Volume 84, Issue 2, Pages (August 2013)
Volume 64, Issue 1, Pages (July 2003)
Volume 90, Issue 1, Pages (July 2016)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 82, Issue 1, Pages (July 2012)
Volume 85, Issue 2, Pages (January 2014)
Aberrant Heparan Sulfate Profile in the Human Diabetic Kidney Offers New Clues for Therapeutic Glycomimetics  Tessa J.M. Wijnhoven, MSc, Joost F.M. Lensen,
Volume 80, Issue 9, Pages (November 2011)
Volume 54, Issue 4, Pages (October 1998)
Volume 87, Issue 2, Pages (February 2015)
Volume 87, Issue 5, Pages (May 2015)
Volume 73, Issue 1, Pages (January 2008)
Volume 77, Issue 11, Pages (June 2010)
Volume 87, Issue 2, Pages (February 2015)
Volume 64, Issue 4, Pages (October 2003)
A new mouse model of immune-mediated podocyte injury
Volume 81, Issue 9, Pages (May 2012)
Volume 56, Issue 2, Pages (August 1999)
Volume 62, Issue 1, Pages (July 2002)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 82, Issue 4, Pages (August 2012)
Volume 67, Issue 2, Pages (February 2005)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 86, Issue 4, Pages (October 2014)
Volume 77, Issue 2, Pages (January 2010)
Volume 66, Issue 3, Pages (September 2004)
Volume 66, Issue 6, Pages (December 2004)
Volume 70, Issue 2, Pages (July 2006)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Volume 68, Issue 4, Pages (October 2005)
Prevention of mesangial sclerosis by bone marrow transplantation
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 71, Issue 7, Pages (April 2007)
Volume 66, Issue 4, Pages (October 2004)
Volume 81, Issue 2, Pages (January 2012)
Volume 75, Issue 5, Pages (March 2009)
Volume 79, Issue 2, Pages (January 2011)
Volume 67, Issue 3, Pages (March 2005)
Volume 85, Issue 1, Pages (January 2014)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 80, Issue 2, Pages (July 2011)
Volume 86, Issue 5, Pages (November 2014)
Glomerular binding of anti-dsDNA autoantibodies: The dispute resolved?
Presentation transcript:

Volume 86, Issue 5, Pages 932-942 (November 2014) Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis  Angelique LWMM Rops, Markus A. Loeven, Jasper J. van Gemst, Iris Eversen, Xander M. Van Wijk, Henry B. Dijkman, Toin H. van Kuppevelt, Jo H.M. Berden, Ton J. Rabelink, Jeffrey D. Esko, Johan van der Vlag  Kidney International  Volume 86, Issue 5, Pages 932-942 (November 2014) DOI: 10.1038/ki.2014.115 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Ndst1 deficiency leads to a decreased glomerular expression of the specific HS domain recognized by AO4B08. (a) Immunofluorescence staining and (b) semiquantitative analysis of the glomerular expression of the inflammatory heparan sulfate (HS) domains recognized by the anti-HS single-chain variable fragment (scFv) antibodies AO4B08, EW3D10, and EW4G2 and of the highly sulfated HS domain recognized by the anti-HS antibody HS4C3 revealed a decreased expression of the HS domain defined by AO4B08 (HS domain with N-, 2-O, and 6-O sulfation, and C5 epimerization) in N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient mice compared with wild-type (WT) mice. Staining intensities are expressed as means±s.e.m. from four Ndst1f/f TEKCre− WT and four Ndst1f/f TEKCre+ (Ndst1f/f) mice in arbitrary units (a.u.). (a) Magnification × 400. (b) *P<0.001 vs. WT mice. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Ndst1 deficiency leads to minor segmental podocyte foot process effacement and focal thickening and irregularities in the glomerular basement membrane (GBM). The glomerular filtration barrier of four wild-type (WT) and four N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient mice, 14–18 weeks old, was analyzed by transmission electron microscopy. WT glomeruli showed the typical pedicel arrangement of podocytes (arrow), whereas in some Ndst1-deficient glomeruli segmental podocyte foot process effacement (arrow) and the presence of thrombocytes (star) were observed. Furthermore, Ndst1-deficient glomeruli showed focal thickening and irregularities in the GBM and some endothelial activation (arrowhead). Magnification × 5000. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Ndst1 deficiency significantly decreases glomerular granulocyte and macrophage influx during anti-GBM nephritis. (a) Glomerular polymorphonuclear granulocyte (PMN) and (b) macrophage influx, analyzed by immunofluorescence staining, peaked at 2h and 1 day, respectively, after rabbit anti-GBM IgG administration in both wild-type (WT) and N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient mice. Ndst1-deficient mice showed a significantly reduced glomerular PMN and macrophage influx during the acute heterologous phase. (c) Glomerular CD4+ T-cell influx was lower in Ndst1-deficient mice compared with WT mice after 1 day but was not significantly different compared with that in untreated controls. In the autologous phase, glomerular CD4+ T-cell and (d) CD8+ T-cell influx in both WT and Ndst1-deficient mice was significantly higher compared with that in both untreated controls. Results are expressed as means±s.e.m. from four control WT and four control Ndst1-deficient mice and five WT and five Ndst1-deficient mice with induced anti-GBM nephritis. **P<0.001 vs. anti-GBM-injected WT mice. *P<0.05 vs. anti-GBM-injected WT mice. ^P<0.05 vs. control. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Ndst1-deficient mice show better renal function during anti-GBM nephritis. (a) The albumin/creatinine ratio (mg/mg) (ACR) was significantly higher in wild-type (WT) mice compared with untreated controls after 1 day during anti-GBM nephritis. N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient mice showed a lower trend in albuminuria at this time point (P=0.06 vs. WT mice). (b) Plasma creatinine concentration (mg/dl) and (c) blood urea nitrogen (BUN) levels (mg/dl) were significantly lower in Ndst1-deficient mice than in WT mice at 4 days. Plasma creatinine concentrations of WT and Ndst1-deficient mice after 2h and 1 day were similar to that of untreated control WT and Ndst1-deficient mice. Results are expressed as means±s.e.m. from four control WT and four control Ndst1-deficient mice and five WT and five Ndst1-deficient mice with induced anti-GBM nephritis. ^P<0.05 vs. control. *P<0.05 vs. anti-GBM-injected WT mice. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Ndst1-deficient mice show less glomerular injury during anti-GBM nephritis. (a) Representative pictures of renal histology and (b) semiquantitative analysis of the percentage of glomeruli with hyalinosis. At least 50 glomeruli per mouse were analyzed for the presence of hyalinosis. Wild-type (WT) mice showed significantly more glomerular injury compared with N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient mice at 1 and 4 days during anti-GBM nephritis. Results are expressed as means±s.e.m. from five WT and five Ndst1-deficient mice. *P<0.05 vs. anti-GBM-injected WT mice. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 6 Ndst1 deficiency significantly reduces the expression of inflammatory heparan sulfate (HS) domains during antiglomerular basement membrane (anti-GBM) nephritis. (a) Immunofluorescence staining and (b) semiquantitative analysis of the glomerular expression of the inflammatory HS domains recognized by anti-HS single-chain variable fragment (scFv) antibodies AO4B08, EW3D10, and EW4G2 and of the highly sulfated HS domain recognized by the anti-HS scFv antibody HS4C3 showed decreased glomerular expression of the inflammatory HS domains at 2h during anti-GBM nephritis in N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient mice compared with wild-type (WT) mice. Staining intensities are expressed as means±s.e.m. from five Ndst1f/f TEKCre− WT and five Ndst1f/f TEKCre+ (Ndst1f/f) mice in arbitrary units (a.u.). (a) Magnification × 400. (b) ^P<0.05 vs. control. *P<0.01 vs. anti-GBM-injected WT mice. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 7 Ndst1 silencing in glomerular endothelial cells leads to decreased adhesion of granulocytes, chemokines and L-selectin in vitro. (a) Adhesion of wild-type (WT) and N-deacetylase-N-sulfotransferase-1 (Ndst1)-deficient granulocytes to a monolayer of Ndst1- or scrambled siRNA (25nM)–transfected, and tumor necrosis factor (TNF)-α-activated, mouse glomerular endothelial cells (mGEnC-1) was measured. Adhesion of granulocytes to tumor necrosis factor (TNF)-α-activated mGEnC-1 that were transfected with scrambled small interfering RNA (siRNA) was set at 100%. (b–d) Glomerular endothelial expression of specific heparan sulfate (HS) domains defined by the anti-HS antibodies AO4B08, EW3D10, EW4G2, and HS4C3 and binding of the chemokines CXCL1, MCP1, and MIP-2α and of recombinant L-selectin to Ndst1-silenced mGEnC-1 were measured with enzyme-linked immunosorbent assay (ELISA). Binding of anti-HS antibodies, chemokines, and L-selectin to control mGEnC-1 was set at 100%. (e) Inhibitory capacity of L-selectin on adhesion of Ndst1-deficient granulocytes to a monolayer of Ndst1-silenced mGEnC-1. Percentage adhesion of Ndst1-deficient granulocytes after blocking with an isotype control is set at 100%. Results are shown as means±s.e.m. from three independent experiments (n=5). *P<0.01 vs. control. ^P<0.05 vs. control. Kidney International 2014 86, 932-942DOI: (10.1038/ki.2014.115) Copyright © 2014 International Society of Nephrology Terms and Conditions